柳药集团：公司完成工商变更登记

Core Viewpoint - Liu Pharmaceutical Group announced changes to its registered capital and corporate governance structure, including the cancellation of the supervisory board and a comprehensive revision of its articles of association, reflecting the company's operational needs and development strategy [1]. Group 1 - The company will hold its second extraordinary general meeting of shareholders on September 15, 2025, to review the proposal regarding changes to registered capital and the cancellation of the supervisory board [1]. - The company has completed the registration change and filing procedures for its articles of association with the approval of the Liuzhou Administrative Approval Bureau, and has obtained a new business license [1].